Literature DB >> 26022814

The remnants of residual risk.

Parag H Joshi1, Seth S Martin1, Roger S Blumenthal2.   

Abstract

Keywords:  LDL-cholesterol; atherosclerosis; remnant lipoproteins; risk factors; triglycerides

Mesh：

Substances：

Year:  2015        PMID： 26022814     DOI： 10.1016/j.jacc.2015.03.543

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  9 in total

1.  New Strategies for Lowering Low Density Lipoprotein Cholesterol for Cardiovascular Disease Prevention.

Authors:  Sean Paul Gaine; Renato Quispe; Jaideep Patel; Erin D Michos
Journal:  Curr Cardiovasc Risk Rep       Date:  2022-06-25

Review 2.  Major Concepts in Treatment with Bempedoic Acid and Inclisiran that Clinicians Need To Know.

Authors:  Johnathon Seth Parham; Anne Carol Goldberg
Journal:  Curr Atheroscler Rep       Date:  2022-06-06       Impact factor: 5.967

3.  Remnant Cholesterol Predicts Risk of Cardiovascular Events in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries.

Authors:  Side Gao; Haobo Xu; Wenjian Ma; Jiansong Yuan; Mengyue Yu
Journal:  J Am Heart Assoc       Date:  2022-05-10       Impact factor: 6.106

4.  Proprotein convertase subtilisin/kexin type 9 enzyme inhibitors: An emerging new therapeutic option for the treatment of dyslipidemia.

Authors:  Faizan Mazhar; Nafis Haider
Journal:  J Pharmacol Pharmacother       Date:  2016 Oct-Dec

5.  Comparison of calculated remnant lipoprotein cholesterol levels with levels directly measured by nuclear magnetic resonance.

Authors:  Jin Chen; Jie Kuang; Xiaoyu Tang; Ling Mao; Xin Guo; Qin Luo; Daoquan Peng; Bilian Yu
Journal:  Lipids Health Dis       Date:  2020-06-10       Impact factor: 3.876

6.  Remnant Cholesterol and Its Visit-to-Visit Variability Predict Cardiovascular Outcomes in Patients With Type 2 Diabetes: Findings From the ACCORD Cohort.

Authors:  Liyao Fu; Shi Tai; Jiaxing Sun; Ningjie Zhang; Ying Zhou; Zhenhua Xing; Yongjun Wang; Shenghua Zhou
Journal:  Diabetes Care       Date:  2022-09-01       Impact factor: 17.152

7.  Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study.

Authors:  Renato Quispe; Seth Shay Martin; Erin Donelly Michos; Isha Lamba; Roger Scott Blumenthal; Anum Saeed; Joao Lima; Rishi Puri; Sarah Nomura; Michael Tsai; John Wilkins; Christie Mitchell Ballantyne; Stephen Nicholls; Steven Richard Jones; Mohamed Badreldin Elshazly
Journal:  Eur Heart J       Date:  2021-11-07       Impact factor: 35.855

8.  Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies.

Authors:  Parag H Joshi; Arif A Khokhar; Joseph M Massaro; Seth T Lirette; Michael E Griswold; Seth S Martin; Michael J Blaha; Krishnaji R Kulkarni; Adolfo Correa; Ralph B D'Agostino; Steven R Jones; Peter P Toth
Journal:  J Am Heart Assoc       Date:  2016-04-29       Impact factor: 5.501

9.  Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial.

Authors:  Yaron Arbel; Robert Klempfner; Aharon Erez; Ilan Goldenberg; Sagit Benzekry; Nir Shlomo; Enrique Z Fisman; Alexander Tenenbaum
Journal:  Cardiovasc Diabetol       Date:  2016-01-22       Impact factor: 9.951
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.